.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Citi
Harvard Business School
Cantor Fitzgerald
Johnson and Johnson
US Army
Boehringer Ingelheim
Fish and Richardson
Cerilliant
Teva

Generated: July 25, 2017

DrugPatentWatch Database Preview

ESZOPICLONE Drug Profile

« Back to Dashboard

Which patents cover Eszopiclone, and when can generic versions of Eszopiclone launch?

Eszopiclone is a drug marketed by Sun Pharma Global, Orchid Hlthcare, Dr Reddys Labs Ltd, Lupin Ltd, Macleods Pharms Ltd, Aurobindo Pharma Ltd, Mylan Pharms Inc, West-ward Pharms Int, Wockhardt Ltd, Glenmark Generics, and Teva. and is included in eleven NDAs.

The generic ingredient in ESZOPICLONE is eszopiclone. There are twenty drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the eszopiclone profile page.

Summary for Tradename: ESZOPICLONE

Patents:0
Applicants:11
NDAs:11
Suppliers / Packagers: see list28
Bulk Api Vendors: see list44
Clinical Trials: see list60
Patent Applications: see list949
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ESZOPICLONE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva
ESZOPICLONE
eszopiclone
TABLET;ORAL091169-002May 23, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark Generics
ESZOPICLONE
eszopiclone
TABLET;ORAL091166-001Apr 15, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva
ESZOPICLONE
eszopiclone
TABLET;ORAL091169-003May 23, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark Generics
ESZOPICLONE
eszopiclone
TABLET;ORAL091166-002Apr 15, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharma Global
ESZOPICLONE
eszopiclone
TABLET;ORAL091103-001Apr 3, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Novartis
Merck
Harvard Business School
Argus Health
Deloitte
Citi
Julphar
Chinese Patent Office
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot